10.6084/m9.figshare.c.3711511_D5.v1 Amy Cranston Amy Cranston Deborah Stocken Deborah Stocken Elaine Stamp Elaine Stamp David Roblin David Roblin Julia Hamlin Julia Hamlin James Langtry James Langtry Ruth Plummer Ruth Plummer Alan Ashworth Alan Ashworth John Burn John Burn Neil Rajan Neil Rajan Additional file 5: of Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial Springer Nature 2017 CYLD defective tumours Tropomyosin receptor kinase (TRK) inhibitor Cylindromatosis TRK inhibition Pegcantratinib CYLD 2017-03-07 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_5_of_Tropomyosin_Receptor_Antagonism_in_Cylindromatosis_TRAC_an_early_phase_trial_of_a_topical_tropomyosin_kinase_inhibitor_as_a_treatment_for_inherited_CYLD_defective_skin_tumours_study_protocol_for_a_randomised_controlled_trial/4732276 SPIRIT figure showing schedule of events in cohort 1 of the trial. (PDF 140 kb)